Related by context. All words. (Click for frequent words.) 68 glycemia 64 HbA1c levels 63 lipid profiles 63 fasting plasma glucose 63 glucose lowering 62 hyperglycemia 62 LDL C 62 statin therapy 61 lipid levels 61 HbA1c 61 diabetes mellitus 60 insulin sensitivity 60 platelet inhibition 60 blood glucose levels 60 NPH insulin 60 A1C levels 60 endothelial function 59 HbA1C 59 hemoglobin A1c levels 59 serum phosphorus 59 arterial stiffness 59 hemoglobin A1c HbA1c 59 cardiometabolic risk 59 HbA 1c 59 T2DM 59 anticoagulation 59 glycosylated hemoglobin levels 58 hyperglycaemia 58 blood glucose 58 nocturnal hypoglycaemia 58 insulin resistance 58 cardiovascular morbidity 58 microvascular complications 58 serum phosphate 58 antihypertensive therapy 58 insulin glargine 58 severe hypoglycemia 57 antihypertensive medications 57 renal function 57 hyperphosphatemia 57 atherogenic dyslipidemia 57 A1c levels 57 glucose tolerance 57 calcium supplementation 57 triglyceride levels 57 glycated hemoglobin levels 57 LDL lowering 57 insulin detemir 57 lipid parameters 57 glycosylated hemoglobin HbA1c 57 primary hypercholesterolemia 57 HDL C 57 CLA supplementation 57 blood Phe levels 57 magnesium intake 57 serum phosphate levels 57 metformin 57 metformin sulphonylurea 57 colesevelam HCl 57 dyslipidaemia 57 glycemic variability 57 tiotropium 57 blood glucose concentrations 56 Glycemic Control 56 liver histology 56 LDL cholesterol lowering 56 tolerability 56 macrovascular 56 tolvaptan 56 Apidra ® 56 Hb A1C 56 lispro 56 postprandial glucose 56 lung function 56 subcutaneous insulin 56 insulin sensitizing 56 A1C 56 hypertensive patients 56 tolerability profile 56 DCCT 56 antidiabetic therapy 56 adiponectin levels 56 vitamin D supplementation 55 triglyceride concentrations 55 glycemic 55 fasting glucose levels 55 metformin monotherapy 55 clinically meaningful 55 resistant hypertension 55 pulmonary exacerbations 55 fasting blood glucose 55 blood lipids 55 fasting plasma glucose FPG 55 paricalcitol 55 β blockers 55 blood sugar 55 lowering blood glucose 55 Lantus ® 55 lowering LDL cholesterol 55 elevated triglyceride levels 55 serum triglycerides 55 dietary intake 55 lipid lowering 55 microalbuminuria 55 mealtime insulin 55 metformin sulfonylurea 55 systolic hypertension 55 HbA 1c levels 55 density lipoprotein HDL cholesterol 55 bosentan 55 subclinical hypothyroidism 55 serum triglyceride levels 55 allopurinol 55 cognitive function 55 basal insulin 55 virologic response 55 LDL cholesterol levels 55 virological response 54 hyperphenylalaninemia HPA due 54 T1DM 54 pioglitazone 54 triglycerides 54 hypercholesterolemia 54 hypoglycemia 54 hemoglobin A1C 54 dapagliflozin plus 54 glimepiride 54 abnormal glucose tolerance 54 sitagliptin 54 antidiabetic drugs 54 DHA supplementation 54 glycated hemoglobin 54 diastolic function 54 insulin lispro 54 serum cholesterol 54 antioxidant supplementation 54 inhaled nitric oxide 54 cardiovascular mortality 54 lipid lowering agents 54 elevated LDL cholesterol 54 LDL cholesterol 54 elevated triglycerides 54 biphasic insulin aspart 54 glucose homeostasis 54 telmisartan 54 HDL cholesterol 54 OADs 54 lipid lowering therapy 54 blood Phe 54 insulin degludec 54 plasma glucose 54 proteinuria 54 gliclazide 54 pulmonary capillary wedge 54 ramipril 54 unfractionated heparin 54 glycosylated hemoglobin 54 antihypertensive drugs 54 antiarrhythmic drug 53 serum urate 53 macrovascular disease 53 Pioglitazone 53 blood phenylalanine Phe 53 ATACAND 53 dose statin therapy 53 hemoglobin A1c 53 serum potassium 53 endothelial dysfunction 53 kidney function 53 metabolic abnormalities 53 vildagliptin 53 pramlintide 53 fasting glucose 53 serum calcium levels 53 systolic BP 53 mean serum phosphorus 53 acting insulin analogues 53 impaired glucose tolerance 53 nonpharmacologic 53 glargine 53 serum urate levels 53 dyslipidemia 53 sulphonylurea 53 serum calcium 53 carotid intima media 53 metabolic parameters 53 dietary folate 53 VADT 53 oral antidiabetic medication 53 sustained virological response 53 diabetes 53 ACE inhibitor ramipril 53 folate supplementation 53 NATRECOR R 53 serum uric acid 53 antiplatelet therapy 53 hypoglycemic episodes 53 cinacalcet 53 DASH diet 53 nondiabetic patients 53 antihypertensive medication 53 CTAP# Capsules 53 statin monotherapy 53 glucose 53 beta blocker therapy 53 ketogenic diet 53 tirofiban 53 zinc supplementation 52 bronchodilation 52 thiazide diuretics 52 lanthanum carbonate 52 improves glycemic 52 dietary supplementation 52 HbA1C levels 52 hsCRP levels 52 hemodynamic parameters 52 co morbidities 52 hour bronchodilation 52 overt nephropathy 52 umol L 52 dietary intakes 52 candesartan 52 macrovascular events 52 reflux symptoms 52 A1c 52 viral suppression 52 fasting triglyceride levels 52 Apidra R 52 platelet reactivity 52 normotensive 52 HAART regimens 52 CaPre TM 52 microvascular disease 52 FOSRENOL ® 52 bone resorption 52 OGTT 52 warfarin therapy 52 adiposity 52 fondaparinux 52 serum glucose 52 baseline HbA1c 52 oral antidiabetic agents 52 postprandial glycemia 52 plasma lipid 52 systolic blood pressure 52 dosing regimens 52 hypertensives 52 serum clusterin levels 52 LANTUS R 52 calcium intake 52 irbesartan 52 anti leukemic 52 mixed hyperlipidemia 52 PYY 52 TZDs 52 #mmHg [001] 52 serum PTH 52 sUA 52 HCTZ 52 angiotensin receptor blocker ARB 52 Diabetes Mellitus 52 ezetimibe Zetia 52 carbohydrate diets 52 plasma triglycerides 52 folic acid supplementation 52 coronary artery disease 52 atherothrombotic events 52 phosphate binders 52 LANTUS ® 52 basal bolus therapy 52 Fasting glucose 52 MULTAQ 52 levosimendan 52 HMG CoA reductase inhibitors 52 renal dysfunction 52 inotropic 52 hypertension 51 left ventricular systolic 51 lipoprotein 51 riociguat 51 lowers blood glucose 51 impaired fasting glucose 51 hyperphosphataemia 51 ORMD 51 IBS symptoms 51 dietary calcium intake 51 Hydroxyurea 51 detemir 51 monotherapy 51 chronic HCV infection 51 #mg/dL [001] 51 desvenlafaxine succinate 51 inadequate glycemic 51 triacylglycerol concentrations 51 macroalbuminuria 51 Lp PLA2 51 Victoza R 51 pharmacologic 51 FOSRENOL R 51 total cholesterol triglycerides 51 Cardiovascular Risk 51 albuminuria 51 ventilatory 51 fat vegan diet 51 Combination therapy 51 dosing frequency 51 paclitaxel eluting stents 51 carotid IMT 51 antidiabetic medications 51 serum lipids 51 prostate carcinogenesis 51 mucosal healing 51 serum sodium 51 NAFLD 51 mg dL 51 NYHA class 51 plasma lipids 51 cardioprotection 51 nicardipine 51 antihypertensive agents 51 incretin 51 extrapyramidal symptoms 51 antithrombotic 51 elevated uric acid 51 Hp2 2 51 aldosterone antagonists 51 fasting insulin 51 dietary patterns 51 6R BH4 51 esomeprazole 51 dual antiplatelet therapy 51 basal bolus regimen 51 bioavailability 51 cholesterol LDL C 51 cholesterol HDL 51 benazepril 51 neurodevelopmental outcomes 51 rHuPH# 51 interferon alfa 2b 51 carvedilol 51 opioid analgesia 51 #mg/day [002] 51 complete cytogenetic response 51 Telmisartan 51 Insulin detemir 51 acarbose 51 postoperative mortality 51 Valsartan 51 left ventricular dysfunction 51 diabetic 51 olmesartan 51 mixed dyslipidemia 51 antiplatelet drugs 51 lipid abnormalities 51 inhaled corticosteroids 51 systolic 51 hepatic glucose production 51 glucose intolerance 51 thiazide diuretic 51 deferiprone 51 serum phosphorous 51 RBP4 51 myocardial reperfusion 51 #.#/#.# mmHg [001] 51 serum concentrations 51 ventricular function 51 glucose metabolism 51 KOMBIGLYZE XR 51 medication adherence 51 HDL Cholesterol 51 unstable angina UA 51 peginterferon 51 insulin sensitizing drugs 51 hemodynamics 51 folate intake 51 postoperative pulmonary 51 venlafaxine XR 51 chromium supplementation 51 supplementation 50 elevated fasting glucose 50 elevated serum creatinine 50 BENICAR HCT 50 anticoagulation therapy 50 DAPT 50 Lp PLA 2 50 fat diet 50 candesartan cilexetil 50 Stop Hypertension diet 50 adefovir 50 thromboembolic 50 PREZISTA r 50 LVEF 50 Insulin PH# 50 antibiotic prophylaxis 50 dose atorvastatin 50 #.#mg/dL 50 adalimumab 50 diastolic heart 50 sustained virologic response 50 antihypertensive 50 diabetes mellitus DM 50 insulin glulisine 50 nondiabetics 50 diabetics 50 cardiovascular calcification 50 pioglitazone HCl 50 antiarrhythmic 50 salmeterol fluticasone 50 cardiac autonomic 50 Monotherapy 50 hyperlipidemia 50 valsartan 50 secondary efficacy endpoints 50 cystatin C 50 metformin sulfonylureas 50 aminotransferases 50 glycated hemoglobin HbA1c 50 vasodilatation 50 cardiorespiratory fitness 50 cirrhotic patients 50 ULORIC 50 serum vitamin D 50 inflammatory markers 50 inflammatory biomarkers 50 BENICAR 50 morphometric vertebral fractures 50 oral glucose tolerance 50 antiplatelet agents 50 thromboprophylaxis 50 teriflunomide 50 dose cytarabine 50 preserved ejection fraction 50 atherosclerosis 50 morbidity mortality 50 neurocognitive function 50 EDARBI 50 urinary albumin 50 randomized trials 50 VIAject 50 daunorubicin 50 ezetimibe simvastatin 50 Hemoglobin A1c 50 serum phosphorus levels 50 androgen deprivation 50 nephrotoxicity 50 glycemic diet 50 thrombotic events 50 retinal thickness 50 Candesartan 50 PSN# [002] 50 metabolic syndrome 50 atherogenic 50 renal impairment 50 pancreatic insufficiency 50 severe hypoglycaemia 50 plasma glucose concentrations 50 comorbid conditions 50 hypercholesterolaemia 50 hypoglycemic events 50 abdominal adiposity 50 rFVIIa 50 hemodynamic 50 TAXUS Stent 50 diabetic gastroparesis 50 serum lipid levels 50 oral antidiabetes 50 nocturnal hemodialysis 50 oral antidiabetic drugs 50 Welchol 50 macrovascular complications 50 serum lipid 50 Protelos 50 CMV infection 50 metabolic acidosis 50 Hypoglycaemia 50 neurologic progression 50 lipid lowering therapies 50 salmeterol HFA MDI 50 demonstrated clinically meaningful 50 glycaemia 50 ISIS # 50 intermittent claudication 50 magnesium supplementation 50 plasma leptin 50 eprotirome 50 apolipoprotein B 50 HSCT 50 VIAject ® 50 KIF6 carriers 50 imatinib therapy 50 intima media thickness 50 oral diclofenac 50 LDL cholesterol concentrations 50 antianginal 50 ALLHAT 50 C reactive protein 50 everolimus eluting stents 50 treprostinil 50 calorie restriction 50 alagebrium 50 spontaneous preterm delivery 50 bezafibrate 50 SYMBICORT 50 Bcl xL 50 sunitinib 50 Hb levels 50 caloric restriction 50 maximally tolerated doses 50 oral anticoagulant therapy 50 coronary revascularization 50 thiazolidinediones 50 insulin sensitization 50 virologic suppression 50 antidepressant therapy 50 Lantus R 50 renoprotective 50 CaPre ™ 49 patients undergoing percutaneous 49 elevated homocysteine 49 rimonabant #mg 49 nonfasting triglyceride levels 49 improves insulin sensitivity 49 total cholesterol LDL 49 APIDRA R 49 myocardial ischemia 49 Stop Hypertension DASH diet 49 nondiabetic 49 exacerbations 49 IFN beta 49 rosuvastatin 49 iPTH 49 IDDM 49 elevated creatinine 49 insulin analogs 49 statins 49 tolerability profiles 49 randomized controlled trials 49 cardiovascular disease CVD 49 plasma glucose levels 49 decompensated heart failure 49 pharmacokinetic PK profile 49 HDL cholesterol triglycerides 49 lumbar spine bone 49 renal insufficiency 49 left ventricular hypertrophy 49 GH deficiency 49 prediabetic 49 coronary heart 49 immune reconstitution 49 statin medications 49 impaired endothelial 49 thromboembolic events 49 posaconazole 49 hyperinsulinemia 49 dose clopidogrel 49 coadministration 49 dexmedetomidine 49 serum insulin 49 CVD mortality 49 alcoholic fatty liver 49 severe hypoglycemic 49 clopidogrel pretreatment 49 dopaminergic therapy 49 alanine aminotransferase ALT 49 levodopa therapy 49 ischemic cardiovascular 49 thyroxine 49 MetS 49 NNT = 49 atorvastatin #mg 49 COPD exacerbations 49 postprandial blood glucose 49 CIPN 49 serum creatinine levels 49 #mg/dL [002] 49 intravascular hemolysis 49 testosterone supplementation 49 dietary modification 49 disease NAFLD 49 fatty acid oxidation 49 VAPRISOL 49 iron supplementation 49 acamprosate 49 dietary sodium 49 decitabine 49 Doxil ® 49 CYPHER Stent 49 nesiritide 49 K DOQI 49 CYP#C# [001] 49 L arginine 49 limiting toxicity 49 tocilizumab 49 obese adolescents 49 MADRS score 49 normalize blood glucose 49 ESRD patients 49 clinically meaningful improvements 49 rosiglitazone 49 noninferiority 49 chlorthalidone 49 triglyceride 49 #.#mmol L [002] 49 intestinal permeability 49 LTRA 49 lowering cholesterol 49 Sitagliptin 49 pulmonary function 49 familial hypercholesterolemia 49 abacavir lamivudine 49 hematologic toxicity 49 chronic ITP 49 lomitapide 49 aripiprazole 49 PASI scores 49 H. pylori eradication 49 SHPT 49 rolofylline 49 diabetes mellitus T2DM 49 antidiabetic 49 mmHg 49 plasma concentrations 49 NovoRapid 49 onset diabetes mellitus 49 elevated ALT 49 left ventricular LV 49 interferon therapy 49 antidiabetic medication 49 proliferative diabetic retinopathy 49 niacin 49 HRQL 49 urinary oxalate 49 PSADT 49 SERCA2a 49 acute coronary syndromes 49 aldosterone 49 antitumor activity 49 UKPDS 49 viral kinetics 49 ulcer healing 49 left ventricular ejection 49 disease progression 49 NYHA Class 49 tissue oxygenation 49 sodium glucose cotransporter 49 lipid profile 49 albumin excretion rate 49 stable angina 49 chronic periodontitis 49 triacylglycerol 49 intact parathyroid hormone 49 nonoperative treatment 49 Caloric restriction 49 antihypertensives 49 tHcy 49 apolipoproteins 49 QTc intervals 49 oral anticoagulation 49 serum folate concentrations 49 loop diuretics 49 CrCl 49 #mg dose [001] 49 adrenal function 49 statin 49 growth hormone secretion 49 LDL HDL ratio 49 severe renal impairment 49 clinically meaningful reductions 49 comorbidities 49 Vitamin D supplementation 49 postoperative AF 49 Calcium intake 49 selenium supplementation 49 ACE Inhibitor 49 antidiabetic agents 49 diabetic kidney 49 levodopa carbidopa 49 systolic function 49 aortic valve stenosis 49 LMWH 49 adjunctive placebo 49 thiazolidinedione 49 serum leptin 49 Diabetic Patients 49 insulin secretion 49 platelet function 49 bronchodilators 49 diastolic blood pressures 49 pulmonary hypertension 49 cardio protective 49 olanzapine 49 deferasirox 49 impaired glucose metabolism 49 T2D 49 glomerular filtration 49 angiographic outcomes 49 incretin hormones 49 MMSE scores 49 hemodialysis patients 49 + PH# 49 prospectively defined 49 infarct size 49 nutrient intake 49 HMG CoA reductase inhibitor 49 flow mediated dilation 49 therapeutic regimens 49 temsirolimus 49 NLX P# 49 fetuin 49 iron overload 49 apoA 49 mitochondrial function 49 serum folate 49 LDL Cholesterol 49 graft patency 49 prediabetes 49 hyperbilirubinemia 49 contrast induced nephropathy 49 pharmacokinetic profile 49 HbA 1C 49 folate 49 pyridostigmine 49 carbohydrate intake 49 efficacy endpoint 49 muscle protein synthesis 49 RE LY 49 prespecified secondary 49 fructosamine 49 lupus nephritis 49 renal artery stenosis 49 serum testosterone 49 intensive statin therapy 49 symptomatic VTE 49 airway responsiveness 49 unfractionated heparin UFH 49 islet transplantation 49 periprocedural 49 ribavirin USP 49 endothelin antagonists 49 HBeAg seroconversion 49 rosuvastatin #mg 49 neurodevelopmental outcome 49 Elitek 49 ADHF 49 lumbar spine BMD 49 abdominal circumference 49 corrected QT interval 49 vascular reactivity 48 peginterferon alfa 2a 48 chronic hemodialysis 48 colorectal adenoma 48 vascular disease 48 perioperative morbidity 48 oral antidiabetic medications 48 antitumor efficacy 48 NYHA functional class 48 nonrandomized 48 ezetimibe 48 #mg/day [001] 48 hepatic fibrosis 48 fatty acid supplementation 48 NovoMix ® 48 amlodipine 48 acting insulins 48 serum retinol 48 dosage regimens 48 psychosocial functioning 48 systemic inflammation 48 erythropoietic 48 RoACTEMRA 48 downregulation 48 pramlintide metreleptin 48 serum cortisol 48 exploratory endpoints 48 ONGLYZA 48 hemoglobin concentration 48 peak VO2 48 STN stimulation 48 aspirin therapy 48 nephropathy 48 diabetic complications 48 angiotensin converting enzyme inhibitors 48 hemoglobin concentrations 48 aldosterone antagonist 48 leucovorin 48 fatty acid intake 48 NATRECOR ® 48 tiotropium bromide 48 albumin excretion 48 LDL 48 Atacand ® 48 graft occlusion 48 Tolvaptan 48 intravesical therapy 48 atherosclerotic disease 48 TREDAPTIVE 48 systolic dysfunction 48 synthase TS 48 mm Hg 48 ApoA1 48 favorable tolerability 48 apoB 48 pioglitazone Actos 48 mm Hg systolic 48 postprandial insulin 48 Endothelial function 48 optimal glycemic 48 transferrin saturation 48 visilizumab 48 Unified Parkinson Disease 48 Technosphere Insulin 48 neurologic outcomes 48 sulphonylureas 48 ACTEMRA TM 48 HIV RNA 48 Glimepiride 48 skeletal muscle mass 48 glipizide 48 post prandial glucose 48 dose aspirin 48 neutrophil counts 48 AVODART 48 creatine supplementation 48 thiamin 48 Levemir ® insulin detemir 48 parkinsonian symptoms 48 QTc interval 48 AA Amyloidosis 48 premixed insulin 48 weekly subcutaneous injections 48 MICARDIS ® 48 uric acid levels 48 folic acid intake 48 STRIDE PD 48 EDSS scores 48 Heterozygous Familial Hypercholesterolemia 48 antidiabetic drug 48 hypoglycaemia 48 zonisamide 48 dose colchicine 48 pharmacological therapies 48 Lovaza ® 48 periprocedural MI 48 depressive symptoms 48 protease inhibitor PI 48 TAXUS Express Stent 48 levodopa 48 insulin 48 adiponectin 48 dietary 48 vidofludimus 48 behavioral interventions 48 trodusquemine 48 glitazones 48 trials RCTs 48 RAPAFLO R 48 revascularization procedures 48 certolizumab 48 serum IGF 48 Levemir 48 Impaired Glucose Tolerance 48 Thiazolidinediones 48 epoetin alfa 48 triglyceride concentration 48 sulfonylurea 48 Hypercholesterolemia 48 endotoxemia 48 gestational diabetes mellitus 48 ribavirin RBV 48 hyperlipidaemia 48 mycophenolate mofetil 48 uncontrolled asthma 48 functional dyspepsia 48 ticagrelor 48 COPAXONE R 48 losartan 48 urate levels 48 Insulin analogues 48 autoantibody levels 48 Nutritional supplementation 48 serum LDL cholesterol 48 fibrinolytic 48 left ventricular diastolic 48 PRTX 48 Epanova 48 potentially modifiable 48 antihyperglycemic 48 aliskiren 48 heterozygous familial 48 elevated blood glucose 48 cardioprotective effects 48 EDSS score 48 airway inflammation 48 Ramipril 48 ancrod 48 CETP inhibition 48 Actos pioglitazone 48 carbohydrate absorption 48 VIAject ™ 48 active comparator 48 hydroxyvitamin D levels 48 pharmacodynamic 48 pulmonary arterial 48 fosamprenavir 48 hepatorenal syndrome 48 calcium intakes 48 fasting serum 48 Parkinson disease PD 48 AZOR 48 hepatic function 48 rosuvastatin Crestor 48 ACTOS ® 48 ziprasidone 48 muraglitazar 48 glulisine 48 rosuvastatin calcium 48 TAXUS VI 48 hyperoxaluria 48 invasive aspergillosis 48 carotid artery intima media 48 LEXIVA 48 cerebral perfusion 48 Haptoglobin 48 abnormal lipids 48 AEGR 48 glucose concentrations 48 BMI z 48 HAQ DI 48 insulin aspart 48 angiotensin receptor blockers 48 colorectal liver metastases 48 lymphocyte counts 48 teriparatide 48 BYSTOLIC 48 cyclic HMB 48 multivitamin supplementation 48 Glucagon 48 antiplatelet therapies 48 PUFA 48 haptoglobin 48 LATUDA 48 lispro alone 48 psoriatic arthritis PsA 48 PlGF 48 strontium ranelate 48 neuropsychiatric symptoms 48 cerebral oxygenation 48 pCR 48 CHD mortality 48 bronchoconstriction 48 lipid metabolism 48 parathyroid hormone PTH 48 gastrointestinal motility 48 fluvastatin 48 orthostatic hypotension 48 triiodothyronine 48 resynchronization therapy 48 thrombolytic agents 48 vitamin D intake 48 ACE inhibitors 48 Atacand 48 adenoma recurrence 48 tapentadol ER 48 amnestic mild cognitive impairment 48 antiemetics 48 reinfarction 48 ADHD symptoms 48 IGFBP 3 48 purpura ITP 48 postprandial glucose levels 48 BH4 48 plus methotrexate 48 variceal bleeding 48 nocturnal hypoglycemia 48 XIENCE V PROMUS Stent 48 polyunsaturated fatty acids PUFAs 48 AVANDIA 48 pharmacological intervention 48 diets 48 elevated CRP 48 antiplatelet medication 48 nitazoxanide 48 glyburide 48 juvenile idiopathic arthritis JIA 48 interpersonal psychotherapy 48 Ranolazine 48 IIIa inhibitor 47 pharmacokinetic parameters 47 diabetic mice 47 improving insulin sensitivity 47 hepatic steatosis 47 lowering triglycerides 47 budesonide formoterol 47 urinary albumin excretion 47 achieved statistical significance 47 Heart Failure 47 metformin HCl 47 thickness CIMT 47 anticoagulant therapy